Loading...
Thumbnail Image
Publication

Dysregulated serum response factor triggers formation of hepatocellular carcinoma.

Ohrnberger, Stefan
Thavamani, Abhishek
Braeuning, Albert
Lipka, Daniel B
Kirilov, Milen
Authenrieth, Stella E
Römer, Michael
Zell, Andreas
Bonin, Michael
... show 6 more
Citations
Altmetric:
Advisors
Editors
Other Contributors
Issue Date
2015-03
Submitted date
Other Titles
Abstract
The ubiquitously expressed transcriptional regulator serum response factor (SRF) is controlled by both Ras/MAPK (mitogen-activated protein kinase) and Rho/actin signaling pathways, which are frequently activated in hepatocellular carcinoma (HCC). We generated SRF-VP16(iHep) mice, which conditionally express constitutively active SRF-VP16 in hepatocytes, thereby controlling subsets of both Ras/MAPK- and Rho/actin-stimulated target genes. All SRF-VP16(iHep) mice develop hyperproliferative liver nodules that progresses to lethal HCC. Some murine (m)HCCs acquire Ctnnb1 mutations equivalent to those in human (h)HCC. The resulting transcript signatures mirror those of a distinct subgroup of hHCCs, with shared activation of oncofetal genes including Igf2, correlating with CpG hypomethylation at the imprinted Igf2/H19 locus.
Citation
Dysregulated serum response factor triggers formation of hepatocellular carcinoma. 2015, 61 (3):979-89 Hepatology
Publisher
PubMed ID
PubMed Central ID
Additional Links
Embedded video
Type
Article
Language
en
Description
Series/Report no.
ISSN
1527-3350
EISSN
ISBN
ISMN
Gov't Doc #
Sponsors
License